Cancer Letters, ISSN 0304-3835, 2008, Volume 267, Issue 2, pp. 226 - 244
Abstract Chemokines, or chemotactic cytokines, and their receptors have been discovered as essential and selective mediators in leukocyte migration to...
Hematology, Oncology and Palliative Medicine | Angiogenesis | GPCR | Tumorigenesis | Metastasis | Chemokines | Cancer | ACTIVATING PEPTIDE-III | angiogenesis | SARCOMA-ASSOCIATED HERPESVIRUS | MICROVASCULAR ENDOTHELIAL-CELLS | DUFFY ANTIGEN RECEPTOR | chemokines | GRANULOCYTE CHEMOTACTIC PROTEIN-2 | AMINO-ACID-SEQUENCE | ONCOLOGY | metastasis | GROWTH STIMULATORY ACTIVITY | METASTATIC BREAST-CANCER | CHRONIC LYMPHOCYTIC-LEUKEMIA | cancer | tumorigenesis | PLATELET FACTOR-IV | Receptors, CXCR - genetics | Humans | Chemokines, CXC - genetics | Amino Acid Motifs | Neoplasms - therapy | Animals | Neoplasms - immunology | Receptors, CXCR - metabolism | Chemokines, CXC - metabolism | Chemokines, CXC - physiology | Mice | Protein Processing, Post-Translational | Receptors, CXCR - physiology | Squamous cell carcinoma | Registered nurses | Glycosaminoglycans | Sarcoma | Development and progression | Glutamate | T cells | Biological response modifiers | Lung cancer, Non-small cell | Membrane proteins | Lymphomas | Fibroblast growth factors | G proteins | Vascular endothelial growth factor | Health aspects | Proteins | Leucocytes | Migration | Cancer therapies | Molecular weight | Immune system | Tumors
Hematology, Oncology and Palliative Medicine | Angiogenesis | GPCR | Tumorigenesis | Metastasis | Chemokines | Cancer | ACTIVATING PEPTIDE-III | angiogenesis | SARCOMA-ASSOCIATED HERPESVIRUS | MICROVASCULAR ENDOTHELIAL-CELLS | DUFFY ANTIGEN RECEPTOR | chemokines | GRANULOCYTE CHEMOTACTIC PROTEIN-2 | AMINO-ACID-SEQUENCE | ONCOLOGY | metastasis | GROWTH STIMULATORY ACTIVITY | METASTATIC BREAST-CANCER | CHRONIC LYMPHOCYTIC-LEUKEMIA | cancer | tumorigenesis | PLATELET FACTOR-IV | Receptors, CXCR - genetics | Humans | Chemokines, CXC - genetics | Amino Acid Motifs | Neoplasms - therapy | Animals | Neoplasms - immunology | Receptors, CXCR - metabolism | Chemokines, CXC - metabolism | Chemokines, CXC - physiology | Mice | Protein Processing, Post-Translational | Receptors, CXCR - physiology | Squamous cell carcinoma | Registered nurses | Glycosaminoglycans | Sarcoma | Development and progression | Glutamate | T cells | Biological response modifiers | Lung cancer, Non-small cell | Membrane proteins | Lymphomas | Fibroblast growth factors | G proteins | Vascular endothelial growth factor | Health aspects | Proteins | Leucocytes | Migration | Cancer therapies | Molecular weight | Immune system | Tumors
Journal Article
BMC Cancer, ISSN 1471-2407, 05/2010, Volume 10, Issue 1, pp. 189 - 189
Background: With the availability of effective anti-EGFR therapies for various solid malignancies, such as non-cell small lung cancer, colorectal cancer and...
GENE-MUTATIONS | LUNG-CANCER | HEAD | CETUXIMAB | ONCOLOGY | COLORECTAL-CANCER | COPY NUMBER | HUMAN-PAPILLOMAVIRUS | EXPRESSION | ACTIVATING MUTATIONS | EGFR KINASE DOMAIN | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Exons | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Molecular Sequence Data | Male | Anal Canal - chemistry | Tonsillar Neoplasms - metabolism | DNA Mutational Analysis | Base Sequence | Polymerase Chain Reaction | Aged, 80 and over | Adult | Female | Anal Canal - pathology | Tonsillar Neoplasms - pathology | Anus Neoplasms - metabolism | Biomarkers, Tumor - analysis | Tonsillar Neoplasms - genetics | In Situ Hybridization, Fluorescence | Proto-Oncogene Proteins - genetics | Anus Neoplasms - pathology | Receptor, Epidermal Growth Factor - analysis | Gene Amplification | Belgium | Anus Neoplasms - genetics | Aged | Biomarkers, Tumor - genetics | Mutation | Cohort Studies | Squamous cell carcinoma | Care and treatment | Ras genes | Gene mutations | Physiological aspects | Genetic aspects | Research | Growth factor receptors | Health aspects | Risk factors
GENE-MUTATIONS | LUNG-CANCER | HEAD | CETUXIMAB | ONCOLOGY | COLORECTAL-CANCER | COPY NUMBER | HUMAN-PAPILLOMAVIRUS | EXPRESSION | ACTIVATING MUTATIONS | EGFR KINASE DOMAIN | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Exons | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Molecular Sequence Data | Male | Anal Canal - chemistry | Tonsillar Neoplasms - metabolism | DNA Mutational Analysis | Base Sequence | Polymerase Chain Reaction | Aged, 80 and over | Adult | Female | Anal Canal - pathology | Tonsillar Neoplasms - pathology | Anus Neoplasms - metabolism | Biomarkers, Tumor - analysis | Tonsillar Neoplasms - genetics | In Situ Hybridization, Fluorescence | Proto-Oncogene Proteins - genetics | Anus Neoplasms - pathology | Receptor, Epidermal Growth Factor - analysis | Gene Amplification | Belgium | Anus Neoplasms - genetics | Aged | Biomarkers, Tumor - genetics | Mutation | Cohort Studies | Squamous cell carcinoma | Care and treatment | Ras genes | Gene mutations | Physiological aspects | Genetic aspects | Research | Growth factor receptors | Health aspects | Risk factors
Journal Article
Trends in Immunology, ISSN 1471-4906, 04/2018, Volume 39, Issue 4, pp. 341 - 354
Chronic skin wounds, caused by arterial or venous insufficiency or by physical pressure, constitute an increasing medical problem as populations age. Whereas...
DIABETES-MELLITUS | MATRIX METALLOPROTEINASES | CHRONIC VENOUS DISEASE | CYTOKINES | NEUTROPHIL | INFLAMMATION | TISSUE REGENERATION | GELATINASE B | POSTTRANSLATIONAL MODIFICATIONS | INHIBITORS | IMMUNOLOGY | Animals | Cytokines - metabolism | Immunomodulation | Humans | Matrix Metalloproteinases | Skin Diseases - immunology | Wound Healing | Chronic Disease | Skin - pathology | Complement System Proteins - metabolism | Health care | Enzymes | Wound healing | Matrix metalloproteinases | Cytokines | Inflammation | Research | Substrates | Defects | Pathology | Angiogenesis | Immunology | Ulcers | Surgery | Stem cells | Healing | Skin | Infiltration | Diabetes | Chemokines
DIABETES-MELLITUS | MATRIX METALLOPROTEINASES | CHRONIC VENOUS DISEASE | CYTOKINES | NEUTROPHIL | INFLAMMATION | TISSUE REGENERATION | GELATINASE B | POSTTRANSLATIONAL MODIFICATIONS | INHIBITORS | IMMUNOLOGY | Animals | Cytokines - metabolism | Immunomodulation | Humans | Matrix Metalloproteinases | Skin Diseases - immunology | Wound Healing | Chronic Disease | Skin - pathology | Complement System Proteins - metabolism | Health care | Enzymes | Wound healing | Matrix metalloproteinases | Cytokines | Inflammation | Research | Substrates | Defects | Pathology | Angiogenesis | Immunology | Ulcers | Surgery | Stem cells | Healing | Skin | Infiltration | Diabetes | Chemokines
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 05/2016, Volume 23, Issue 17, pp. 1725 - 1755
Serum amyloid A (SAA) is, like C-reactive protein (CRP), an acute phase protein and can be used as a diagnostic, prognostic or therapy follow-up marker for...
Cytokines | Amyloidosis | FPR2 | Leukocytes | Saa variants | Chemotaxis | Inflammatory diseases | TLR2 | C-REACTIVE PROTEIN | SYSTEMIC-LUPUS-ERYTHEMATOSUS | CHEMISTRY, MEDICINAL | amyloidosis | BIOCHEMISTRY & MOLECULAR BIOLOGY | inflammatory diseases | NECROSIS-FACTOR-ALPHA | HIGH-DENSITY-LIPOPROTEIN | PREMATURE CORONARY ATHEROSCLEROSIS | OBSTRUCTIVE PULMONARY-DISEASE | ACUTE-PHASE PROTEINS | FORMYL PEPTIDE RECEPTOR | SAA variants | leukocytes | PHARMACOLOGY & PHARMACY | cytokines | NF-KAPPA-B | SIGNAL-TRANSDUCTION PATHWAY | chemotaxis | Genomic Structural Variation - genetics | Serum Amyloid A Protein - genetics | Serum Amyloid A Protein - chemistry | Serum Amyloid A Protein - metabolism | Humans
Cytokines | Amyloidosis | FPR2 | Leukocytes | Saa variants | Chemotaxis | Inflammatory diseases | TLR2 | C-REACTIVE PROTEIN | SYSTEMIC-LUPUS-ERYTHEMATOSUS | CHEMISTRY, MEDICINAL | amyloidosis | BIOCHEMISTRY & MOLECULAR BIOLOGY | inflammatory diseases | NECROSIS-FACTOR-ALPHA | HIGH-DENSITY-LIPOPROTEIN | PREMATURE CORONARY ATHEROSCLEROSIS | OBSTRUCTIVE PULMONARY-DISEASE | ACUTE-PHASE PROTEINS | FORMYL PEPTIDE RECEPTOR | SAA variants | leukocytes | PHARMACOLOGY & PHARMACY | cytokines | NF-KAPPA-B | SIGNAL-TRANSDUCTION PATHWAY | chemotaxis | Genomic Structural Variation - genetics | Serum Amyloid A Protein - genetics | Serum Amyloid A Protein - chemistry | Serum Amyloid A Protein - metabolism | Humans
Journal Article
Cytokine and Growth Factor Reviews, ISSN 1359-6101, 2010, Volume 22, Issue 1, pp. 1 - 18
Abstract Chemokines are chemotactic cytokines which recruit leukocytes to inflammatory sites. They also affect tumor development and metastasis by acting as...
Advanced Basic Science | Chemokine | Angiogenesis | Platelet factor-4 variants | CXCR3 | Cancer | ENDOTHELIAL-CELL PROLIFERATION | ACTIVATED PROTEIN-C | MURINE CEREBRAL MALARIA | BIOCHEMISTRY & MOLECULAR BIOLOGY | LOW-DENSITY-LIPOPROTEIN | HEPARIN-INDUCED THROMBOCYTOPENIA | FIBROBLAST-GROWTH-FACTOR | HUMAN MONOCYTES | CELL BIOLOGY | AMINO-ACID-SEQUENCE | IN-VIVO | PLATELET FACTOR-IV
Advanced Basic Science | Chemokine | Angiogenesis | Platelet factor-4 variants | CXCR3 | Cancer | ENDOTHELIAL-CELL PROLIFERATION | ACTIVATED PROTEIN-C | MURINE CEREBRAL MALARIA | BIOCHEMISTRY & MOLECULAR BIOLOGY | LOW-DENSITY-LIPOPROTEIN | HEPARIN-INDUCED THROMBOCYTOPENIA | FIBROBLAST-GROWTH-FACTOR | HUMAN MONOCYTES | CELL BIOLOGY | AMINO-ACID-SEQUENCE | IN-VIVO | PLATELET FACTOR-IV
Journal Article
European Journal of Immunology, ISSN 0014-2980, 01/2015, Volume 45, Issue 1, pp. 101 - 112
Serum amyloid A (SAA) is an acute phase protein that is upregulated in inflammatory diseases and chemoattracts monocytes, lymphocytes, and granulocytes via its...
Serum amyloid A | Monocytes | DCs | Chemotaxis | Chemokines | MIGRATION | A-PROTEIN | ACTIVATION | RELEASE | IMMUNOLOGY | IDENTIFICATION | ACUTE-PHASE RESPONSE | PROTEIN-COUPLED RECEPTOR | PATHWAY | DISEASE | EXPRESSION | Interleukin-8 - genetics | Dose-Response Relationship, Immunologic | Chemokine CCL3 - immunology | Monocytes - cytology | Serum Amyloid A Protein - pharmacology | Dendritic Cells - immunology | Humans | Receptors, CCR5 - genetics | Monocytes - immunology | Chemokine CCL3 - antagonists & inhibitors | Interleukin-8 - agonists | Receptors, CCR5 - immunology | Chemokine CCL3 - genetics | Dendritic Cells - drug effects | Receptors, CCR1 - immunology | Chemotaxis - immunology | Cell Line | Signal Transduction | Gene Expression Regulation | Antibodies, Neutralizing - pharmacology | Chemotaxis - drug effects | Interleukin-8 - antagonists & inhibitors | Recombinant Proteins - pharmacology | Monocytes - drug effects | Receptors, CCR1 - genetics | Diffusion Chambers, Culture | Chemokine CXCL12 - pharmacology | Dendritic Cells - cytology | Primary Cell Culture | Interleukin-8 - immunology | Receptors, CCR1 - antagonists & inhibitors | G proteins | Peptides | Dendritic cells | Membrane proteins | Proteins | Leucocytes | Ligands
Serum amyloid A | Monocytes | DCs | Chemotaxis | Chemokines | MIGRATION | A-PROTEIN | ACTIVATION | RELEASE | IMMUNOLOGY | IDENTIFICATION | ACUTE-PHASE RESPONSE | PROTEIN-COUPLED RECEPTOR | PATHWAY | DISEASE | EXPRESSION | Interleukin-8 - genetics | Dose-Response Relationship, Immunologic | Chemokine CCL3 - immunology | Monocytes - cytology | Serum Amyloid A Protein - pharmacology | Dendritic Cells - immunology | Humans | Receptors, CCR5 - genetics | Monocytes - immunology | Chemokine CCL3 - antagonists & inhibitors | Interleukin-8 - agonists | Receptors, CCR5 - immunology | Chemokine CCL3 - genetics | Dendritic Cells - drug effects | Receptors, CCR1 - immunology | Chemotaxis - immunology | Cell Line | Signal Transduction | Gene Expression Regulation | Antibodies, Neutralizing - pharmacology | Chemotaxis - drug effects | Interleukin-8 - antagonists & inhibitors | Recombinant Proteins - pharmacology | Monocytes - drug effects | Receptors, CCR1 - genetics | Diffusion Chambers, Culture | Chemokine CXCL12 - pharmacology | Dendritic Cells - cytology | Primary Cell Culture | Interleukin-8 - immunology | Receptors, CCR1 - antagonists & inhibitors | G proteins | Peptides | Dendritic cells | Membrane proteins | Proteins | Leucocytes | Ligands
Journal Article
BBA - Reviews on Cancer, ISSN 0304-419X, 2012, Volume 1825, Issue 1, pp. 117 - 129
Chronic inflammation may increase the risk to develop cancer, for instance esophagitis or gastritis may lead to development of esophageal or gastric cancer,...
Chemokine | Esophagitis | Angiogenesis | Inflammation | Cancer | Gastritis | INDUCED INTERLEUKIN-8 PRODUCTION | MESSENGER-RNA EXPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | NECROSIS-FACTOR-ALPHA | FACTOR-KAPPA-B | BARRETTS-ESOPHAGUS | NEUTROPHIL-ACTIVATING PROPERTIES | BIOPHYSICS | LYMPH-NODE METASTASIS | EPITHELIAL-CELLS | ONCOLOGY | HELICOBACTER-PYLORI INFECTION | EPIDERMAL-GROWTH-FACTOR | Care and treatment | Oncology, Experimental | Gastrointestinal system | Development and progression | Research | Neovascularization | Stomach cancer | Esophageal cancer | Tumors
Chemokine | Esophagitis | Angiogenesis | Inflammation | Cancer | Gastritis | INDUCED INTERLEUKIN-8 PRODUCTION | MESSENGER-RNA EXPRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | NECROSIS-FACTOR-ALPHA | FACTOR-KAPPA-B | BARRETTS-ESOPHAGUS | NEUTROPHIL-ACTIVATING PROPERTIES | BIOPHYSICS | LYMPH-NODE METASTASIS | EPITHELIAL-CELLS | ONCOLOGY | HELICOBACTER-PYLORI INFECTION | EPIDERMAL-GROWTH-FACTOR | Care and treatment | Oncology, Experimental | Gastrointestinal system | Development and progression | Research | Neovascularization | Stomach cancer | Esophageal cancer | Tumors
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 11/2016, Volume 7, p. 483
Chemokines are small, chemotactic proteins that play a crucial role in leukocyte migration and are, therefore, essential for proper functioning of the immune...
Chemokine | Posttranslational modification | Leukocyte migration | Proteolysis | Glycosaminoglycan | GPCR | CD26 | Dipeptidyl peptidase IV | chemokine | MACROPHAGE-DERIVED CHEMOKINE | COLONY-STIMULATING FACTOR | posttranslational modification | leukocyte migration | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | NEUROPEPTIDE-Y NPY | MYELIN BASIC-PROTEIN | MATRIX METALLOPROTEINASES | CHEMOTACTIC ACTIVITY | IN-VIVO | dipeptidyl peptidase IV | glycosaminoglycan | AMINO-TERMINAL TRUNCATION | proteolysis | ENDOTHELIAL GROWTH-FACTOR | Research | Proteases | Analysis | Chemokines
Chemokine | Posttranslational modification | Leukocyte migration | Proteolysis | Glycosaminoglycan | GPCR | CD26 | Dipeptidyl peptidase IV | chemokine | MACROPHAGE-DERIVED CHEMOKINE | COLONY-STIMULATING FACTOR | posttranslational modification | leukocyte migration | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | NEUROPEPTIDE-Y NPY | MYELIN BASIC-PROTEIN | MATRIX METALLOPROTEINASES | CHEMOTACTIC ACTIVITY | IN-VIVO | dipeptidyl peptidase IV | glycosaminoglycan | AMINO-TERMINAL TRUNCATION | proteolysis | ENDOTHELIAL GROWTH-FACTOR | Research | Proteases | Analysis | Chemokines
Journal Article